In this study, the JAK2-V617F mutation had the highest detection rate in PV (91.3%), relative to ET (69.1%) and PMF (62.5%), which was consistent with the literature [13–16], followed by the CALR gene mutation. The gene discussed is JAK2; the disease is essential thrombocythemia.